Schrodinger, Inc. (SDGR, Financial) experienced a notable stock movement with a 5.11% increase in its share price, reaching $25.30. The trading volume was 444,555 shares, with a turnover rate of 0.61% and a price fluctuation of 6.90%. Recent financial reports reveal Schrodinger generated revenue of $35.29 million, with a net loss of $38.14 million, translating to an earnings per share of -$0.52. The gross profit stood at $17.73 million, and the price-to-earnings ratio was -10.29.
In terms of analyst ratings, 73% of the 11 institutions covering the stock recommend buying, while 27% suggest holding, with no sell recommendations. Schrodinger operates within the health information services sector, which saw an overall increase of 1.46%. Other stocks in this sector showing significant gains include Onemednet Corp, Genedx Holdings Corp, and Vsee Health Inc. Notably active stocks were Aclarion, Inc., Icoreconnect Inc., and Foxo Technologies Inc., with turnover rates of 229.69%, 18.77%, and 9.35%, respectively. Stocks with high volatility included Aclarion Inc, Vsee Health Inc, and Msp Recovery Inc, with amplitude fluctuations of 38.76%, 36.07%, and 29.55%.
Schrodinger, Inc. is a healthcare software company focusing on software sales and drug discovery. It earns revenue through its software solutions, research funding, and milestone payments from drug discovery collaborations.
